Juan Francisco Sánchez-Ávila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juan Francisco Sánchez-Ávila has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Campos-Murguía
Hepatology and Liver Transplantation Unit, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, México
1 shared publication- Antonio Olivas-Martinez
Department of Biostatistics University of Washington Seattle Washington USA
1 shared publication - Carlos Jerjes-Sanchez
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
1 shared publication - Daniel Almaguer-Morales
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey, Mexico
1 shared publication - Enrique Paredes‐Gutierrez
Tecnologico de Monterrey Escuela de Medicina y Ciencias de la Salud Monterrey Nuevo Leon Mexico
1 shared publication Eric Kauffman-Ortega
Hepatology and Liver Transplantation Unit, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, México
1 shared publication
Latest Publications
- 14 October 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Short‐Term Complications of Transcatheter Aortic Valve Replacement: A Systematic Review and Meta‐Analysis (PROLONG‐TAVR)
To estimate the cumulative incidence of short‐term complications across different transcatheter heart valve (THV) prostheses used for transcatheter aortic valve replacement (TAVR). We performed a systematic review and meta‐analysis in accordance with PRISMA and a prospectively registered PROSPERO protocol. Observational studies published from 2002 through May 2024 that included patients with severe aortic stenosis undergoing predominantly transfemoral TAVR and reported prosthesis‐specific complications were eligible. Although the original protocol intended to evaluate both short‐ and long‐term complications, long‐term outcomes were too sparse and inconsistently reported for robust pooled analyses; therefore, the present analysis focuses on short‐term complications. Pooled cumulative incidences were calculated using random‐effects models. We included 242 studies comprising 181,187 patients. SAPIEN 3 had the lowest incidence of moderate‐to‐severe paravalvular leak (PVL) (1.04%, 95% CI 0.69–1.55) and stroke (1.87%, 95% CI 1.64–2.14), whereas ACURATE neo2 had the lowest incidence of permanent pacemaker implantation (PPI) (7.7%, 95% CI 5.82–10.11). Evolut PRO and SAPIEN 3 showed among the lowest rates of major vascular complications (3.56%, 95% CI 2.77–4.57 and 3.87%, 95% CI 3.22–4.66, respectively) and major or life‐threatening bleeding (2.96%, 95% CI 2.09–4.17 and 4.8%, 95% CI 4.04–5.69, respectively). Short‐term complications have decreased with newer‐generation THV prostheses. PVL remains more frequent with self‐expanding valves, whereas PPI is the most frequent complication and is generally less frequent with balloon‐expandable valves and ACURATE neo2. Stroke rates have changed little across newer generations, and annular rupture, coronary artery obstruction, and valve embolization remain rare (< 1%).
- 14 October 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Short‐Term Complications of Transcatheter Aortic Valve Replacement: A Systematic Review and Meta‐Analysis (PROLONG‐TAVR)
To estimate the cumulative incidence of short‐term complications across different transcatheter heart valve (THV) prostheses used for transcatheter aortic valve replacement (TAVR). We performed a systematic review and meta‐analysis in accordance with PRISMA and a prospectively registered PROSPERO protocol. Observational studies published from 2002 through May 2024 that included patients with severe aortic stenosis undergoing predominantly transfemoral TAVR and reported prosthesis‐specific complications were eligible. Although the original protocol intended to evaluate both short‐ and long‐term complications, long‐term outcomes were too sparse and inconsistently reported for robust pooled analyses; therefore, the present analysis focuses on short‐term complications. Pooled cumulative incidences were calculated using random‐effects models. We included 242 studies comprising 181,187 patients. SAPIEN 3 had the lowest incidence of moderate‐to‐severe paravalvular leak (PVL) (1.04%, 95% CI 0.69–1.55) and stroke (1.87%, 95% CI 1.64–2.14), whereas ACURATE neo2 had the lowest incidence of permanent pacemaker implantation (PPI) (7.7%, 95% CI 5.82–10.11). Evolut PRO and SAPIEN 3 showed among the lowest rates of major vascular complications (3.56%, 95% CI 2.77–4.57 and 3.87%, 95% CI 3.22–4.66, respectively) and major or life‐threatening bleeding (2.96%, 95% CI 2.09–4.17 and 4.8%, 95% CI 4.04–5.69, respectively). Short‐term complications have decreased with newer‐generation THV prostheses. PVL remains more frequent with self‐expanding valves, whereas PPI is the most frequent complication and is generally less frequent with balloon‐expandable valves and ACURATE neo2. Stroke rates have changed little across newer generations, and annular rupture, coronary artery obstruction, and valve embolization remain rare (< 1%).
- 1 October 2021
- Published by Elsevier in Archives of Medical Research
- Vol. 52 (7) , 713-718
Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort.
- 1 October 2021
- Published by Elsevier in Archives of Medical Research
- Vol. 52 (7) , 713-718
Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort.
- Open Access
- 1 September 2021
- Published by Elsevier in Annals of Hepatology
- Vol. 24, 100382
P-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO
- 1 September 2021
- Published by Elsevier in Annals of Hepatology
- Vol. 24, 100382
Open AccessP-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO